Showing results (261-270 of 284) with videos related to
Sort By:
Pageof 29
Vaccine|June 9, 2020
Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccinesPaul-Henri Lambert, Donna M Ambrosino, Svein R Andersen, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 17, 2023
Mosaic RBD Nanoparticles Elicit Protective Immunity Against Multiple Human Coronaviruses in Animal ModelsYanjun Zhang, Jing Sun, Jian Zheng, et al.Vaccine|March 4, 2023
A research and development (R&D) roadmap for broadly protective coronavirus vaccines: A pandemic preparedness strategyKristine A Moore, Tabitha Leighton, Julia T Ostrowsky, et al.Science Immunology|August 6, 2017
Recovery from the Middle East respiratory syndrome is associated with antibody and T-cell responsesJingxian Zhao, Abeer N Alshukairi, Salim A Baharoon, et al.Nature|March 22, 2022
Eicosanoid signalling blockade protects middle-aged mice from severe COVID-19Lok-Yin Roy Wong, Jian Zheng, Kevin Wilhelmsen, et al.Nature Immunology|March 15, 2024
Antibody-independent protection against heterologous SARS-CoV-2 challenge conferred by prior infection or vaccinationValeria Fumagalli, Micol Ravà, Davide Marotta, et al.Science Translational Medicine|February 19, 2016
Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivoThomas Luke, Hua Wu, Jincun Zhao, et al.The Journal of Clinical Investigation|January 8, 2025
CXCL12 ameliorates neutrophilia and disease severity in SARS-CoV-2 infectionJian Zheng, Hima Dhakal, Enya Qing, et al.Cell|June 20, 2020
A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing AntibodiesAhmed O Hassan, James Brett Case, Emma S Winkler, et al.Emerging Infectious Diseases|April 26, 2021
Longevity of Middle East Respiratory Syndrome Coronavirus Antibody Responses in Humans, Saudi ArabiaAbeer N Alshukairi, Jincun Zhao, Maha A Al-Mozaini, et al.Pageof 29